Rose V. Thomas

In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine

Robert Yarchoan, Hiroaki Mitsuya, Rose V. Thomas et al. · Science · 1989 · 425 citations

Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

Raymond W. Klecker, Jerry M. Collins, Robert Yarchoan et al. · Clinical Pharmacology & Therapeutics · 1987 · 381 citations

Suramin: an anticancer drug with a unique mechanism of action.

C.A. Stein, R. V. Larocca, Rose V. Thomas et al. · Journal of Clinical Oncology · 1989 · 373 citations

Tumor Innervation, Pathology, Pharmacotherapy +17

RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINE

Robert Yarchoan, Pim Brouwers, A R Spitzer et al. · The Lancet · 1987 · 356 citations

Neurovirology, Human Retrovirus, Antiviral Therapy +6

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

Robert Yarchoan, James M. Pluda, Rose V. Thomas et al. · The Lancet · 1990 · 215 citations

Medicine, Immunology, Long-term Toxicity/activity Profile +6